Equities

Mycodern SA

Mycodern SA

Actions
  • Price (EUR)--
  • Today's Change--
  • Shares traded0.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Mycodern SA is a Poland-based company primarily engaged in the food processing. The Company is a producer of functional food and cutting-edge dietary supplements. The company specializes in the production of dietary supplements and functional foods, including the production of vitamin jellies. The company's offer includes products in the form of hard capsules, softgel capsules, functional shots, oil and liquid forms, as well as functional gummies. The Company produces both its own brands and carries out contract orders for other entities. The Company's research and development department allows to develop its own recipes. The Company's products are sold in over 25 countries, including Europe and beyond. The Company has a modern machine park and develops distribution channels.

  • Revenue in PLN (TTM)6.58m
  • Net income in PLN-6.70m
  • Incorporated2011
  • Employees23.00
  • Location
    Mycodern SAul. Jaskowa Dolina 132/20GDANSK 80-286PolandPOL
  • Phone+48 323182723
  • Fax+48 322238468
  • Websitehttps://mycodern.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.